NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/19/2026
Back to search
Official data from USPTO
OPTIMER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/20/2026
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
06/29/2021
Registration date
12/10/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/10/2024
Last transaction
03/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
GB
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "OPTIMER" in a stylized font.
Holders and representatives
Holders
Aptamer Group Limited
Representatives
Charles J. Meyer Woodard, Emhardt, Henry, Reeves & Wagner
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for medical use; chemical reagents for medical use; medicalveterinaryclinicaldiagnostic and pharmaceutical reagentsagentschemicalsmaterialssubstances and preparationsclinical medical reagentsreagents for medical useveterinary diagnostic reagentschemical reagents for medical purposesdiagnostic agentspreparations and substances for medical purposes; optimised aptamer molecules for medical and veterinary useveterinary diagnostic reagentschemical reagents for medical purposesdiagnostic media for bacteriological cultures; medical and veterinary diagnostic reagents and assays for testing of body fluids; medical and veterinary diagnostic test strips for the analysis of bloodurinesalivahuman tissue and animal tissue; diagnostic biomarker reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic or treatment purposesdiagnostic reagents and contrast media for medical use; nucleic acids for medicalveterinarydiagnostic and pharmaceutical purposesnucleic acids being diagnostic reagents and chemical reagents for medical and veterinary purposes; nucleic acid sequences for medicalveterinarydiagnostic and pharmaceutical purposes; diagnostic testing kits comprised of medical diagnostic reagentsassaysmonoclonal antibodiesbuffers and reagents for testing of bodily fluidshuman tissue and animal tissue for use in disease detection; diagnostic reagents for medical and veterinary use for sale in kit form; diagnostic kits comprising specimen receptors and reagents for medicalveterinary and diagnostic testing in the nature of diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluidshuman tissue and animal tissue for use in disease detection; medical and veterinary diagnostic reagents and assays for testing of fluids
Class 42
Research and development services in the field of medical diagnostics and medical testing; product design and development of diagnostic apparatusinstrumentsequipmenttools and devices; product researchdesign and development in the field of diagnostic preparations; product researchdesign and development of reagents; product researchdesign and development of aptamer reagents; product researchdesign and development of aptamer reagents for integration into diagnostic platforms; product researchdesign and development of reagents for therapeutic applications; product researchdesign and development of aptamer reagents for therapeutic applications; custom product development of reagents; custom product development of aptamer reagents; medical researchoptimsation of aptamer molecules; product researchdesign and development of nucleic acids for medicalveterinarydiagnostic and pharmaceutical purposes; product researchdesign and development of nucleic acid sequences for medicalveterinarydiagnostic and pharmaceutical purposes laboratory testing servicestesting of pharmaceuticals; medical and scientific laboratory services for analytical testing; design and development of testing and analysis methodsresearch and development of advanced learning technologies and teaching methods; medical and scientific laboratory servicespreparation of biological samples for testing and analysis in research laboratories; medical and veterinary research services; medical and veterinary laboratory services; scientific research and investigations for medical and veterinary purposes; medical and scientific laboratory servicesanalysis of human and animal tissues and samples for medical and veterinary research; biological researchclinical researchmedical research and veterinary research in the field of medical diagnostics and medical testing; provision of information and data relating to medical and veterinary research and development; information and advisory services in respect of the aforementioned services
Class 44
Medicalveterinary and diagnostic servicesmedical testing for diagnostic or treatment purposesvirus testing for medical diagnostic or treatment purposesveterinary testing for diagnostic or treatment purposes; medical and veterinary testing servicesgenetic testing for medicaldiagnostic and treatment purposesveterinary testing for diagnostic or treatment purposes; medical and veterinary testing for diagnostic or treatment purposes; medical and veterinary analysis services for diagnostic and treatment purposesmedical analysis for the diagnosis and treatment of personsmedical analysis for the diagnosis and treatment of animals; medical and veterinary testing services relating to diagnosis and treatment; medical and veterinary analysis servicesmedical analysis for the diagnosis and treatment of personsmedical analysis for the diagnosis and treatment of animals; information and advisory services in respect of the aforementioned services
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/24/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/08/2025
FIMP
FINAL DISPOSITION PROCESSED
05/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2024
PUBO
PUBLISHED FOR OPPOSITION
09/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/05/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/31/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/11/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/19/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
12/19/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2022
RFNT
REFUSAL PROCESSED BY IB
07/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2022
RFRR
REFUSAL PROCESSED BY MPU
06/14/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/14/2022
CNRT
NON-FINAL ACTION WRITTEN
05/13/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/10/2022
DOCK
ASSIGNED TO EXAMINER
05/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/05/2022
Continuous trademark protection
Get notified about every new filing that threatens OPTIMER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.